New insights into a spectrum of developmental malformations related to mTOR dysregulations: challenges and perspectives
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
In recent years the role of the mammalian target of rapamycin (mTOR) pathway has emerged as crucial for normal cortical development. Therefore, it is not surprising that aberrant activation of mTOR is associated with developmental malformations and epileptogenesis. A broad spectrum of malformations of cortical development, such as focal cortical dysplasia (FCD) and tuberous sclerosis complex (TSC), have been linked to either germline or somatic mutations in mTOR pathway‐related genes, commonly summarised under the umbrella term ‘mTOR opathies’. However, there are still a number of unanswered questions regarding the involvement of mTOR in the pathophysiology of these abnormalities. Therefore, a monogenetic disease, such as TSC, can be more easily applied as a model to study the mechanisms of epileptogenesis and identify potential new targets of therapy. Developmental neuropathology and genetics demonstrate that FCD II b and hemimegalencephaly are the same diseases. Constitutive activation of mTOR signalling represents a shared pathogenic mechanism in a group of developmental malformations that have histopathological and clinical features in common, such as epilepsy, autism and other comorbidities. We seek to understand the effect of mTOR dysregulation in a developing cortex with the propensity to generate seizures as well as the aftermath of the surrounding environment, including the white matter.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The role of inflammation in epilepsy
Vezzani, A., French, J., Bartfai, T., & Baram, T. Z. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.178 · Cited by 1,876
The Tuberous Sclerosis Complex
Crino, P. B., Nathanson, K. L., & Henske, E. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmra055323 · Cited by 1,793
Northrup, H., Krueger, D. A., Northrup, H., Krueger, D. A., Roberds, S., Smith, K., Sampson, J., Korf, B., Kwiatkowski, D. J., Mowat, D., et al. (2013) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2013.08.001 · Cited by 1,502
Development of the human cerebral cortex: Boulder Committee revisited
Bystron, I., Blakemore, C., & Rakic, P. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2252 · Cited by 977 · cited 1×
“…is another aspect that must be considered in brain maturation, without which processes such as synaptogenesis and the formation of synaptic circuits and networks that generate normal brain function and epileptic states cannot be fully appreciated (Bystron et al. 2006, 2008; Clowry et al. 2010).”
BackgroundShape and arrangement of columns in cat's striate cortex
Hubel, D. H., & Wiesel, T. N. (1963) · The Journal of Physiology · doi:10.1113/jphysiol.1963.sp007079 · Cited by 834 · cited 1×
“Nevertheless, radial columnar synaptic pathways continue in the cortex after maturation, despite the additional development of horizontal pathways between columns (Hubel & Wiesel, 1963; Mountcastle, 1997).”
BackgroundFrench, J. A., Lawson, J. A., Yapici, Z., Ikeda, H., Polster, T., Nabbout, R., Curatolo, P., de Vries, P. J., Dlugos, D. J., Berkowitz, N., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31419-2 · Cited by 764
Finding of Rare Disease Genes (FORGE) Canada Consortium, Rivière, J.-B., Mirzaa, G. M., O'Roak, B. J., Beddaoui, M., Alcantara, D., Conway, R. L., St-Onge, J., Schwartzentruber, J. A., Gripp, K. W., et al. (2012) · Nature Genetics · doi:10.1038/ng.2331 · Cited by 741 · cited 2×
“…malformation syndrome, congenital lipomatous overgrowth, vascular malformations and epidermal naevi (CLOVE) syndrome and FCD (Poduri et al. 2012; Riviere et al. 2012; Mirzaa & Poduri, 2014; D’Gama et al. 2015; Jansen et al. 2015; Desikan & Barkovich, 2016; Mirzaa et al. 2016; Table 1).”
BackgroundAllendoerfer, K. L., & Shatz, C. J. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.001153 · Cited by 653
Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2
Tavazoie, S. F., Alvarez, V. A., Ridenour, D. A., Kwiatkowski, D. J., & Sabatini, B. L. (2005) · Nature Neuroscience · doi:10.1038/nn1566 · Cited by 497 · cited 1×
“The mechanistic link between genetic mutations, dysregulation of mTOR pathway and excitatory/ inhibitory synaptic imbalance leading to hyperexcitability has also been supported by different experimental studies (Tavazoie et al. 2005; Bateup et al. 2013; Lozovaya et al. 2014; Santos et al. 2017).”
ResultInvited review: Neuropathology of tauopathies: principles and practice
Kovacs, G. G. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12208 · Cited by 492
The mTOR signalling cascade: paving new roads to cure neurological disease
Crino, P. B. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.81 · Cited by 368 · cited 1×
“These findings show large phenotypic variability that could reflect the involvement of other modifier genes or mechanisms of epigenetic regulation that is still incompletely understood (Mirzaa & Poduri, 2014; Jansen et al. 2015; Crino, 2016).”
BackgroundJansen, L. A., Mirzaa, G. M., Ishak, G. E., O'Roak, B. J., Hiatt, J. B., Roden, W. H., Gunter, S. A., Christian, S. L., Collins, S., Adams, C., et al. (2015) · Brain · doi:10.1093/brain/awv045 · Cited by 364 · cited 4×
“…mutations in different genes acting as regulators of the mTOR signalling, including PTEN, PI3KCA, AKT (Schick et al. 2006; Conti et al. 2015; Jansen et al. 2015), DEPDC5 and NPRL3 (both components of the mTOR regulatory GATOR1 complex; Baulac et al. 2015; Scerri et al. 2015; Sim et al.…”
BackgroundInfluentialInflammation in epilepsy: Clinical observations
Aronica, E., & Crino, P. B. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03033.x · Cited by 306 · cited 1×
“…as neuromodulators, directly affecting neuronal function and excitability and contributing to the mechanisms of seizure generation, epileptogenesis and cognitive dysfunction (for review see Aronica & Crino, 2011; Vezzani et al. 2011, 2012, 2015; Aronica et al. 2012b, 2017; van Vliet et al. 2018).”
BackgroundSelf-citationTuberous Sclerosis registry to increase disease Awareness (TOSCA): baseline data on 2093 patients
on behalf of TOSCA consortium and TOSCA investigators, Kingswood, J. C., d’Augères, G. B., Belousova, E., Ferreira, J. C., Carter, T., Castellana, R., Cottin, V., Curatolo, P., Dahlin, M., et al. (2017) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-016-0553-5 · Cited by 267
mTOR: A pathogenic signaling pathway in developmental brain malformations
Crino, P. B. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.07.008 · Cited by 266
Ribierre, T., Deleuze, C., Bacq, A., Baldassari, S., Marsan, E., Chipaux, M., Muraca, G., Roussel, D., Navarro, V., Leguern, E., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99384 · Cited by 241
The genomic landscape of tuberous sclerosis complex
Martin, K. R., Zhou, W., Bowman, M. J., Shih, J., Au, K. S., Dittenhafer-Reed, K. E., Sisson, K. A., Koeman, J., Weisenberger, D. J., Cottingham, S. L., et al. (2017) · Nature Communications · doi:10.1038/ncomms15816 · Cited by 238 · cited 6×
“burden is low, which is consistent with their slow growing character (Bongaarts et al. 2017; Martin et al. 2017).”
BackgroundInfluentialActivation of toll-like receptor, RAGE and HMGB1 signalling in malformations of cortical development
Zurolo, E., Iyer, A., Maroso, M., Carbonell, C., Anink, J. J., Ravizza, T., Fluiter, K., Spliet, W. G. M., van Rijen, P. C., Vezzani, A., et al. (2011) · Brain · doi:10.1093/brain/awr032 · Cited by 207 · cited 2×
“…that contain different cell types, including dysmorphic neurones, giant cells and reactive astrocytes (Mizuguchi & Takashima, 2001; Boer et al. 2008a; Grajkowska et al. 2010; Zurolo et al. 2011; Aronica et al. 2012a; Aronica & Crino, 2014; Aronica & Muhlebner, 2017; Curatolo et al. 2018b).”
BackgroundSelf-citationNeuropathology of tuberous sclerosis
Mizuguchi, M., & Takashima, S. (2001) · Brain and Development · doi:10.1016/s0387-7604(01)00304-7 · Cited by 205
Loss of Tsc1 In Vivo Impairs Hippocampal mGluR-LTD and Increases Excitatory Synaptic Function
Bateup, H. S., Takasaki, K. T., Saulnier, J. L., Denefrio, C. L., & Sabatini, B. L. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1617-11.2011 · Cited by 204
Noninflammatory Changes of Microglia Are Sufficient to Cause Epilepsy
Zhao, X., Liao, Y., Morgan, S., Mathur, R., Feustel, P., Mazurkiewicz, J., Qian, J., Chang, J., Mathern, G. W., Adamo, M. A., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.004 · Cited by 190 · cited 1×
“…models point to a possible role for microglia abnormalities (resulting from Tsc1 inactivation) in contributing to epileptogenesis; however, whether microglial cells are primary contributors to epilepsy and associated comorbidities is still matter of discussion (Zhang et al. 2018; Zhao et al. 2018).”
BackgroundManagement of epilepsy associated with tuberous sclerosis complex: Updated clinical recommendations
Curatolo, P., Nabbout, R., Lagae, L., Aronica, E., Ferreira, J. C., Feucht, M., Hertzberg, C., Jansen, A. C., Jansen, F., Kotulska, K., et al. (2018) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2018.05.006 · Cited by 190
Self-citationThe first neurons of the human cerebral cortex
Bystron, I., Rakic, P., Molnár, Z., & Blakemore, C. (2006) · Nature Neuroscience · doi:10.1038/nn1726 · Cited by 183 · cited 1×
“…is another aspect that must be considered in brain maturation, without which processes such as synaptogenesis and the formation of synaptic circuits and networks that generate normal brain function and epileptic states cannot be fully appreciated (Bystron et al. 2006, 2008; Clowry et al. 2010).”
BackgroundBiallelic TSC gene inactivation in tuberous sclerosis complex
Crino, P. B., Aronica, E., Baltuch, G., & Nathanson, K. L. (2010) · Neurology · doi:10.1212/wnl.0b013e3181e04325 · Cited by 153 · cited 1×
“The same mechanism (‘two-hit’ model with somatic inactivation of TSC1/TSC2) has been suggested to explain tuber formation in TSC (Crino et al. 2010; Qin et al. 2010).”
BackgroundSelf-citationBlümcke, I., Vinters, H. V., Armstrong, D., Aronica, E., Thom, M., & Spreafico, R. (2009) · Epileptic Disorders · doi:10.1684/epd.2009.0261 · Cited by 145
Self-citationTau reduction prevents disease in a mouse model of Dravet syndrome
Gheyara, A. L., Ponnusamy, R., Djukic, B., Craft, R. J., Ho, K., Guo, W., Finucane, M. M., Sanchez, P. E., & Mucke, L. (2014) · Annals of Neurology · doi:10.1002/ana.24230 · Cited by 138 · cited 1×
“…2015) provides additional potential mechanisms contributing to the intrinsic neuronal network hyper-excitability characteristic of these MCD and may suggest new targets for therapeutic intervention (Xi et al. 2011; Jones et al. 2012; Kearney, 2013; Gheyara et al. 2014; Liu et al. 2016).”
BackgroundLiu, S.-J., Zheng, P., Wright, D. K., Dezsi, G., Braine, E., Nguyen, T., Corcoran, N. M., Johnston, L. A., Hovens, C. M., Mayo, J. N., et al. (2016) · Brain · doi:10.1093/brain/aww116 · Cited by 127 · cited 1×
“SEGAs are low-grade glioneuronal tumours classified as WHO grade I and represent 1–2% of all paediatric brain tumours (Jozwiak et al. 2015; Louis et al. 2016).”
BackgroundMühlebner, A., van Scheppingen, J., Hulshof, H. M., Scholl, T., Iyer, A. M., Anink, J. J., van den Ouweland, A. M. W., Nellist, M. D., Jansen, F. E., Spliet, W. G. M., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0157396 · Cited by 88 · cited 9×
“…prominent inflammation, increased gliosis and prominent myelin loss) occurs more often in very young children and possibly reflects the time point of tuber formation leading to such severe pathological changes already in the early stages of cerebral development (Muhlebner et al. 2016b).”
BackgroundInfluentialSelf-citationIntrinsic epileptogenicity of cortical tubers revealed by intracranial EEG monitoring
Mohamed, A. R., Bailey, C. A., Freeman, J. L., Maixner, W., Jackson, G. D., & Harvey, A. S. (2012) · Neurology · doi:10.1212/wnl.0b013e3182768923 · Cited by 81 · cited 2×
“Although epilepsy surgery often results in freedom from seizures, increasing evidence supports the importance of the perituberal cortex in TSC (Madhavan et al. 2007; Wang et al. 2007; Major et al. 2009; Moshel et al. 2010; Mohamed et al. 2012; Fallah et al. 2015; Fujiwara et al. 2016; Liang et al. 2017).”
BackgroundTargeting hyperphosphorylated tau with sodium selenate suppresses seizures in rodent models.
Jones, N. C., Nguyen, T., Corcoran, N. M., Velakoulis, D., Chen, T., Grundy, R., O'Brien, T. J., & Hovens, C. M. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.005 · Cited by 81
Sarnat, H. B., & Flores-Sarnat, L. (2015) · Brain and Development · doi:10.1016/j.braindev.2014.08.010 · Cited by 73
Self-citationAn international consensus classification for focal cortical dysplasias
Blümcke, I., & Spreafico, R. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70225-8 · Cited by 73 · cited 2×
“FCD type II refers to an isolated malformation characterised by disrupted cortical lamination and cytological abnormalities and includes two subtypes, FCDIIa (with dysmorphic neurones, but without balloon cells) and FCDIIb (with dysmorphic neurones and balloon cells; Blumcke & Spreafico, 2011).”
BackgroundMicroRNA expression patterns in human astrocytes in relation to anatomical location and age.
Rao, V. T. S., Ludwin, S. K., Fuh, S.-C., Sawaya, R., Moore, C. S., Ho, M.-K., Bedell, B. J., Sarnat, H. B., Bar-Or, A., & Antel, J. P. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlv016 · Cited by 50 · cited 1×
“Furthermore, micro-RNAs show that there also are lamina-specific differences in astrocytes within the mature cortex and less such expression in the fetus, except for some scattered white matter and germinal matrix astrocytes that show greater maturity by single cell examination (Rao et al. 2016).”
BackgroundSelf-citation
Cited by
New insights into the development of the human cerebral cortex
Molnár, Z., Clowry, G. J., Šestan, N., Alzu'bi, A., Bakken, T., Hevner, R. F., Hüppi, P. S., Kostović, I., Rakic, P., Anton, E. S., et al. (2019) · Journal of Anatomy · doi:10.1111/joa.13055 · Cited by 401
mTOR and neuroinflammation in epilepsy: implications for disease progression and treatment
Ravizza, T., Scheper, M., Di Sapia, R., Gorter, J., Aronica, E., & Vezzani, A. (2024) · Nature Reviews Neuroscience · doi:10.1038/s41583-024-00805-1 · Cited by 141
“In addition, FCDIIb exhibits a more robust expression of innate and adaptive immunity components than FCDIIa (lacking balloon cells), although seizure burden was similar in all patients.”
InfluentialSelf-citationEpileptogenesis in tuberous sclerosis complex-related developmental and epileptic encephalopathy
Aronica, E., Specchio, N., Luinenburg, M. J., & Curatolo, P. (2023) · Brain · doi:10.1093/brain/awad048 · Cited by 74
Self-citationSpecchio, N., Nabbout, R., Aronica, E., Auvin, S., Benvenuto, A., de Palma, L., Feucht, M., Jansen, F., Kotulska, K., Sarnat, H., et al. (2023) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2023.08.005 · Cited by 58
Self-citationZimmer, T. S., Broekaart, D. W. M., Gruber, V.-E., van Vliet, E. A., Mühlebner, A., & Aronica, E. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.01028 · Cited by 48
“The aforementioned studies imply strong phenotypic effects, depending on the timing of the mutation, as well as the cell type affected, potentially explaining the phenotypic heterogeneity of dysmorphic cells and in particular astrocytes in human TSC (27).”
InfluentialSelf-citation
Metadata
- Authors
- Mühlebner, A., Bongaarts, A., Sarnat, H. B., Scholl, T., & Aronica, E.
- Venue
- Journal of Anatomy
- Publisher
- Wiley
- Published
- 2019-03-22
- Volume
- 235
- Issue
- 3
- Pages
- 521-542
- ISSN
- 0021-8782 (ISSN-L)
- 1469-7580
- OpenAlex
- W2945737519
- Cited by
- 99
- References
- 33
- FWCI
- 6.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.